Clinical Trials Sponsored by Estetra S.A.

Total 3233 results

Eurofarma Laboratorios S.A.

Withdrawn

Non-Inferiority Trial Comparing Eurofarma's Experimental Product Saccharomyces Boulardii Versus Floratil® in the Prevention of Antibiotic-Associated Diarrhea (ACROSS)

Antibiotics

Brazil
Eurofarma Laboratorios S.A.

Withdrawn

Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBIC

Gastroesophageal Reflux Disease

Brazil
Eurofarma Laboratorios S.A.

Terminated

Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation (VECOR)

Unstable Angina | Non ST Segment Elevation Myocardial Infarction

Brazil
Stendhal Americas, S.A.

Completed

Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential Hypertension (FIRME-1)

Hypertension, Essential

Mexico
Steba Biotech S.A.

Terminated

Study Using WST11 in Patients With Obstructing Endobronchial Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

France
Ferrer Internacional S.A.

Completed

Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension.

Hypertension
Eurofarma Laboratorios S.A.

Withdrawn

Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)

Adenocarcinoma | Carcinoma | Uterine Cervix Adenosquamous Carcinoma

Brazil
BioTech Tools S.A.

Completed

Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TM

Hay Fever

Germany
BioTech Tools S.A.

Completed

Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating Adjuvant

Hay Fever

Belgium
Janssen-Cilag, S.A.

Completed

Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With Schizophrenia (PRE-COG)

Schizophrenia
EDAP TMS S.A.

Unknown

Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer

Prostate Cancer

United States, Canada
Eurofarma Laboratorios S.A.

Completed

A Study of Chemoradiation Associated With Nimotuzumab as the Treatment of Locally Advanced Esophageal Cancer (NICE)

Adenocarcinoma | Esophageal Cancer

Brazil
Janssen-Cilag, S.A.

Completed

A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis

Vaginitis | Infectious Vaginosis

Mexico
Janssen-Cilag, S.A.

Completed

A Study to Evaluate Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease
Eurofarma Laboratorios S.A.

Terminated

A Non-inferiority Study Comparing Two Heparin Sodium Preparations in Hip Fracture Surgery (HEP-SC)

Hip Fracture Surgery

Brazil
Faes Farma, S.A.

Completed

Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)

Chronic Urticaria | Allergic Rhinoconjunctivitis

Australia, Germany, Sweden
Faes Farma, S.A.

Completed

Oral Bioavailability of Bilastine (BIOBI)

Healthy

Spain
Faes Farma, S.A.

Completed

Efficacy Study for the Symptomatic Treatment of Perennial Allergic Rhinitis With a 1 Year Safety Extension

Perennial Allergic Rhinitis
Ferrer Internacional S.A.

Terminated

A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol

Elevated LDL Cholesterol

United States
Addex Pharma S.A.

Completed

ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease

Parkinson's Disease

United States, Austria, France, Germany
Addex Pharma S.A.

Completed

ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD)

Gastroesophageal Reflux

United States, France, Germany, Netherlands, Switzerland
Eurofarma Laboratorios S.A.

Completed

A Non-inferiority, Multicenter and Randomized, Single-Dose Study About a Treatment to Hypolactasia (LAILAI) (EF099)

Hypolactasia

Brazil
Faes Farma, S.A.

Completed

A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With Bilastine

Seasonal Allergic Rhinitis
Faes Farma, S.A.

Completed

A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challenge Chamber

Seasonal Allergic Rhinitis

Austria
Janssen-Cilag, S.A.

Completed

A Study to Evaluate the Safety and Effectiveness of Fentanyl-TTS Compared to Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDS (Non-steroidal Anti-inflammatory Drugs).

Pain
Janssen-Cilag, S.A.

Terminated

Safety of Rabeprazole in Patients Under Multiple Treatments

Gastroesophageal Reflux | Gastric Ulcer
Janssen-Cilag, S.A.

Terminated

Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorders
Grünenthal Colombiana S.A.

Completed

Cost-effectiveness Study of Beclomethasone Versus Ciclesonide as Controller Medications in Pediatric Asthma

Asthma

Colombia
BioTech Tools S.A.

Completed

Clinical Safety and Tolerability Study of gpASIT+TM and gpASIT+TM/Immunoregulating Adjuvant to Treat Seasonal Grass Pollen Rhinoconjunctivitis

Seasonal Allergic Rhinoconjunctivitis

Belgium
Ferrer Internacional S.A.

Completed

Study to Assess the Efficacy and Safety of GF-001001-00 Cream in Secondarily-Infected Traumatic Lesions

Secondarily Infected Traumatic Lesions

Germany
Laboratorios Goulart S.A.

Unknown

Open and Comparative Study to Measure Tolerability and Efficacy of Taro Elixir (E01GOU-INH0109)

Boils | Acne Vulgaris II or III Degree

Brazil
Laboratoires Expanscience S.A.

Completed

Evaluation of the Structure Modifying Effect of Avocado-Soybean Unsaponifiables in Hip Osteoarthritis (ERADIAS)

Hip Osteoarthritis

France
Addex Pharma S.A.

Completed

ADX10059 as a Monotherapy in Patients With Gastroesophageal Reflux (GERD)

Gastroesophageal Reflux

Austria, Belgium, France, Germany
University of Primorska
Elettra Synchrotron Trieste

Completed

Long Term Effects of Different Dietary Protocols on Determinants of Health in Patients' Lymphocytes (FTIR)

Asymptomatic Condition

Slovenia
Mayo Clinic
Entera Health, Inc

Terminated

Manage Diarrhea in Patients With Multiple Myeloma While Receiving Conditioning Chemotherapy for Autologous SCT

Multiple Myeloma

United States
Northwestern University
Entera Health, Inc

Terminated

To Evaluate the Impact of SBI on C. Difficile in Hospitalized UC Patients

Clostridium Difficile

United States
Industrial Farmacéutica Cantabria, S.A.

Not yet recruiting

A Pilot Study to Evaluate the Systemic Effect of Oral Supplementation With AM3 in Patients With Metabolic Syndrome.

Metabolic Syndrome
Human Biome Institute S.A.

Recruiting

Fecal Microbiota Transplantation (FMT) to Decolonize Antibiotic - Resistant Bacteria (ARB) - New Protocol (STOP-ARB2)

Antimicrobial Drug Resistance | Drug Resistance, Bacterial

Poland
Bial - Portela C S.A.

Recruiting

OpiCapone Effect on Motor Fluctuations and pAiN (OCEAN)

Parkinson Disease

United Kingdom
Roxall Medicina España S.A

Recruiting

Study to Evaluate the Safety of Treatment With A"LLERGOVAC® HIMENÓPTEROS" in Patients Sensitized to This Venom (HIPNOS)

Allergy to Himenoptera Venom

Spain
Nyxoah S.A.
Nyxoah Inc.

Active, not recruiting

Dual-sided Hypoglossal neRvE stimulAtion for the treatMent of Obstructive Sleep Apnea (DREAM) (DREAM)

Obstructive Sleep Apnea

United States, Australia, Belgium, Germany
Philip Morris Products S.A.

Completed

Nicotine Pharmacokinetics Following Use of the P4M3 Gen 2.0 E-Cigarette Compared to Smoking Cigarettes

Nicotine | Nicotine Vaping | Vaping

United States
Azidus Brasil
Farmoquimica S.A.

Completed

Efficacy And Safety Of Probiatop In The Treatment Of Digestive Symptoms (Probiatop)

Signs and Symptoms, Digestive

Brazil
Philip Morris Products S.A.

Terminated

Cross-Sectional Survey on the Use of Tobacco Products - London (UK)

Tobacco Use

Switzerland
Bial - Portela C S.A.

Completed

Safety and Efficacy of BIA 5-1058 in PAH

Pulmonary Arterial Hypertension

Austria, Germany, Italy, Portugal, Spain, United Kingdom
Tedec-Meiji Farma, S.A.

Completed

Efficacy and Safety of Repeated Intraarticular Injections of Hyaluronic Acid in Patients With OA of the Knee

Osteoarthritis of the Knee
Philip Morris Products S.A.

Completed

Reduced Exposure to HPHC in Smokers Switching From Cigarettes to Different Versions of THS

Smoking | Tobacco Use | Tobacco Smoking

United Kingdom
Philip Morris Products S.A.

Withdrawn

Effect of Switching From Cigarette Smoking to THS on Systemic Endothelial Function in Subjects With Established Atherosclerotic Disease

Cardiovascular Diseases | Coronary Artery Disease | Smoking | Peripheral Arterial Disease | Tobacco Use
Bial - Portela C S.A.

Active, not recruiting

Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study) (EPSILON)

Parkinson

Bulgaria
A-Mansia Biotech S.A.

Completed

Study to Evaluate the Effect of Pasteurized Akkermansia Muciniphila (pAkk) on Complaints Related to IBS

Irritable Bowel Syndrome

Germany

3

Subscribe